On Friday, Coeur Mining Inc (CDE) stock saw a decline, ending the day at $6.18 which represents a decrease of $-0.01 or -0.16% from the prior close of $6.19. The stock opened at $6.15 and touched a ...
President-elect Donald Trump will be sworn in for his second term on Monday amid a bitter blast of frigid air that has forced ...
Equities researchers at Cantor Fitzgerald reduced their FY2024 earnings estimates for nLIGHT in a research report issued on Thursday, January 16th. Cantor Fitzgerald analyst T. Jensen now expects that ...
Hosted on MSN2d
Cantor Fitzgerald Initiates Coverage of NICE - Depositary Receipt () (NICE) with Neutral RecommendationFintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of NICE - Depositary Receipt () (NasdaqGS:NICE) ...
Hosted on MSN2d
Cantor Fitzgerald Initiates Coverage of DigitalOcean Holdings (DOCN) with Neutral RecommendationFintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of DigitalOcean Holdings (NYSE:DOCN) with a ...
Howard Lutnick, Donald Trump's Commerce Secretary, who's also among the founding members of the Department of Government ...
Cantor Fitzgerald upgraded shares of NICE (NASDAQ:NICE – Free Report) to a hold rating in a research note issued to investors on Thursday, MarketBeat reports. The brokerage currently has $176.00 price ...
DigitalOcean Holdings Inc (DOCN) stock saw a modest uptick, ending the day at $36.13 which represents a slight increase of $0.86 or 2.44% from the prior close of $35.27. The stock opened at $35.7 and ...
Cantor Fitzgerald raised the firm’s price target on Rubrik (RBRK) to $85 from $70 and keeps an Overweight rating on the shares. Rubrik has performed well since its April 2024 IPO, and its ...
Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...
Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, commercial-stage biotechnology company with two approved ...
Cantor Fitzgerald initiated coverage of MongoDB (MDB) with an Overweight rating and $344 price target Stay Ahead of the Market:Discover ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback